ストックスクリーナーアプリを入手
0.00
100.00%
-2.07
前日終値:
$2.07
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$89.08M
収益：
$16.77M
当期純損益:
$-11.87M
株価収益率:
0.00
EPS:
-0.4742
ネットキャッシュフロー:
$-5.90M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$3.2459
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
IPA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
0.00 | 89.08M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-02 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-25 | 開始されました | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd (IPA) 最新ニュース
What hedge fund activity signals for ImmunoPrecise Antibodies Ltd. stockTrade Volume Report & AI Forecast for Swing Trade Picks - ulpravda.ru
Is ImmunoPrecise Antibodies Ltd. (TQB) stock worth holding before Fed meetingWeekly Volume Report & Risk Controlled Daily Trade Plans - ulpravda.ru
How ImmunoPrecise Antibodies Ltd. stock benefits from tech adoptionJuly 2025 Final Week & Risk Managed Investment Entry Signals - ulpravda.ru
Is ImmunoPrecise Antibodies Ltd. stock supported by strong cash flows2025 Earnings Impact & Weekly Stock Breakout Alerts - ulpravda.ru
What analysts say about ImmunoPrecise Antibodies Ltd TQB stockTechnical Breakout Signals & Learn the Basics of Investing in 5 Days - earlytimes.in
What is the fair value of ImmunoPrecise Antibodies Ltd. stock nowTrendline Breakouts & Outstanding Investment Portfolio - bollywoodhelpline.com
Why ImmunoPrecise Antibodies Ltd. stock is seen as undervaluedRisk Management & Community Trade Idea Sharing Platform - Улправда
Travel Stocks: Can ImmunoPrecise Antibodies Ltd. stock rebound after recent weakness2025 Trading Volume Trends & Long-Term Capital Growth Strategies - moha.gov.vn
Is ImmunoPrecise Antibodies Ltd. stock trading near support levelsPortfolio Growth Summary & Accurate Intraday Trade Tips - Улправда
Growth Report: What is the fair value of ImmunoPrecise Antibodies Ltd. stock now2025 Key Highlights & Scalable Portfolio Growth Methods - Улправда
Can ImmunoPrecise Antibodies Ltd. stock beat market expectations this quarterQuarterly Trade Review & Free Technical Confirmation Trade Alerts - Улправда
Is ImmunoPrecise Antibodies Ltd. stock a buy in volatile markets2025 Fundamental Recap & Accurate Technical Buy Alerts - DonanımHaber
Aug Decliners: Can ImmunoPrecise Antibodies Ltd. stock beat market expectations this quarterWeekly Market Outlook & Daily Profit Maximizing Tips - Улправда
Why ImmunoPrecise Antibodies Ltd. stock appeals to analystsJuly 2025 Trade Ideas & Precise Buy Zone Tips - Улправда
How ImmunoPrecise Antibodies Ltd. stock trades before earningsDividend Hike & Free Long-Term Investment Growth Plans - Улправда
Will ImmunoPrecise Antibodies Ltd. stock benefit from automationMarket Performance Report & High Conviction Buy Zone Alerts - Улправда
Can ImmunoPrecise Antibodies Ltd. stock rebound after recent weaknessEarnings Risk Report & Growth Focused Stock Pick Reports - Улправда
How analysts rate ImmunoPrecise Antibodies Ltd. stock todayJuly 2025 Final Week & AI Driven Price Predictions - Улправда
ImmunoPrecise Antibodies Ltd Stock Analysis and ForecastMarket Sentiment Surveys & Zero-Cost Stock Research by Professionals - earlytimes.in
How ImmunoPrecise Antibodies Ltd. stock responds to policy changes2025 Performance Recap & High Conviction Investment Ideas - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock benefit from infrastructure billWeekly Market Outlook & Low Risk High Win Rate Stock Picks - Newser
Is ImmunoPrecise Antibodies Ltd. (TQB) stock positioned for secular growthCPI Data & Fast Gaining Stock Strategy Reports - Newser
What earnings margins imply for ImmunoPrecise Antibodies Ltd. (TQB) stockWeekly Earnings Recap & Expert Approved Trade Ideas - Newser
Published on: 2025-12-03 04:40:50 - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock hit analyst forecastsWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
What momentum indicators show for ImmunoPrecise Antibodies Ltd. stockBull Run & Verified Technical Signals - Newser
Published on: 2025-12-02 06:55:07 - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock remain on Wall Street radarGap Down & AI Powered Trade Plan Recommendations - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock gain from lower interest ratesMarket Growth Review & High Accuracy Buy Signal Tips - Newser
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 5.6% – Should You Sell? - Defense World
What drives ImmunoPrecise Antibodies Ltd stock priceEarnings Miss Alerts & Affordable Capital Growth - earlytimes.in
Is ImmunoPrecise Antibodies Ltd. stock positioned well for digital economyWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Is ImmunoPrecise Antibodies Ltd. (TQB) stock attractive for growth fundsWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
How ImmunoPrecise Antibodies Ltd. (TQB) stock reacts to Fed tighteningJuly 2025 Price Swings & Expert Verified Movement Alerts - newser.com
What RSI levels show for ImmunoPrecise Antibodies Ltd. (TQB) stockLayoff News & Verified Momentum Stock Alerts - newser.com
Is ImmunoPrecise Antibodies Ltd. stock attractive for ETFsJuly 2025 Decliners & Long-Term Growth Plans - newser.com
What earnings revisions data tells us about ImmunoPrecise Antibodies Ltd.July 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Will ImmunoPrecise Antibodies Ltd. stock recover faster than peersTrade Volume Summary & Free Growth Oriented Trading Recommendations - newser.com
Immunoprecise Antibodies Ltd (IPA) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):